Brain Tumor Case Presentations (February 8, 2024)
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Neuroscience Tumor Board session will take place on February 8, 2024 at 7:00 a.m. This series is restricted to tumor board participants and will not be broadcast.
Activity Information
Needs Statement
Neurosurgeons, neuro-oncologists, neuroradiologists, neuropathologists, radiation oncologists, fellows, residents, and healthcare professionals in related disciplines need to receive regular updates on advances in neuroscience, developments in the surgical and radiotherapeutic management of brain tumors, and the evidence-based results of clinical trials. The tumor board aims to use a multidisciplinary team approach and complex case reviews to advance the knowledge of learners, promote the personalization of treatment plans, enhance the quality of brain cancer care, and improve patient outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Identify different types of brain tumors based on their radiographic features.
- Discuss the pathologic features of each type of brain tumor.
- Review and evaluate the surgical and radiotherapeutic treatment options for brain tumors.
- Recognize how a multidisciplinary team can improve the medical care of patients with brain tumors.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Neurology
- Neurosurgery
- Oncology
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Jacob Mandel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Advisory Committee Membership: Kiyatec, Inc.
- Honorarium Recipient: Bayer Pharmaceuticals
-
Akash J. Patel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Directors
-
Jacob Mandel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Advisory Committee Membership: Kiyatec, Inc.
- Honorarium Recipient: Bayer Pharmaceuticals
-
Akash J. Patel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
-
Abdul Basit Khan, M.D.
Neurosurgery Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jacob Mandel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
- Advisory Committee Membership: Kiyatec, Inc.
- Honorarium Recipient: Bayer Pharmaceuticals
-
Akash J. Patel, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
-
Sherly Sebastian, D.N.P., R.N., NP-C
Assistant Professor, Nurse Practitioner
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenters: